Drug Product Manufacturing Plan
NerPharMa DP dealing with the development and manufacturing of finished dosage forms: injectables (solutions, suspensions and lyophilized products) and solid oral (tablets and capsules) for various therapeutic areas, not just oncological.
Able to handle cytotoxic and cytostatic compounds and execute activities of formulation, packaging and clinical supply.
Manufacturing Capabilities
NerPharMa can manufacture, in its high containment facilities, the following pharmaceutical forms both for commercial and clinical trial purposes:
Oral solid dose and semi-solid products
Tablets by direct compression, wet and dry granulation processes
Hard Capsules filled with powders, tablets, liquids and semisolids
Sterile product
Solutions and suspensions aseptically manufactured or terminally sterilized
Freeze-dried vials
Versatility and Flexibility: batch size as low as 50-200 g and as high as 200 L and 50 Kg for sterile and non sterile products, respectively.
Technology assets:
1
lab-scale
lyophilizer
2
lyophilizers
1
sterile production
line for vials
1
sterile production line
for large volume in bags
1
line for non sterile
Lyo product
2
lines with
HyNap Technology
4
solid forms
production suites
1
lab-scale lyophilizer
2
lyophilizers
1
sterile production line for vials
1
sterile production line for large volume in bags
1
line for non sterile
Lyo product
2
lines with
HyNap Technology
1
solid forms
production suites
Other Services
Need information?
Please contact us if you would like to arrange a visit to your company by one of our representatives, to request a proposal, or for any more information on our services.
Welcome and Check out our new motion picture!